Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Ferron

Showing results (41-50 of 78) with videos related to

Pageof 8
Sort By:
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|April 22, 2014
[Radiotherapy as conservative therapy for sarcomas within the irradiated field]A Modesto, T Filleron, C Chevreau, et al.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|April 3, 2007
[Sentinel node detection applied to breast cancer: 2007 update]J-M Classe, G Houvenaeghel, C Sagan, et al.
Annals of Surgical Oncology|April 5, 2020
Should We Abandon Systematic Pelvic and Paraaortic Lymphadenectomy in Low-Grade Serous Ovarian Cancer?V Simon, C Ngo, E Pujade-Lauraine, et al.
Gynecologic Oncology|June 2, 2016
Results of a multicenter phase I dose-finding trial of hyperthermic intraperitoneal cisplatin after neoadjuvant chemotherapy and complete cytoreductive surgery and followed by maintenance bevacizumab in initially unresectable ovarian cancerS Gouy, G Ferron, O Glehen, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 4, 2009
Factors predicting the sentinel node metastases in T1 breast cancer tumor: an analysis of 1416 casesJ Capdet, P Martel, H Charitansky, et al.
Annals of Surgical Oncology|March 24, 2016
Surgical Complexity Impact on Survival After Complete Cytoreductive Surgery for Advanced Ovarian CancerA Martinez, C Ngo, E Leblanc, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 28, 2011
Prognostic factors for patients treated for a recurrent FIGO stage III ovarian cancer: a retrospective study of 108 casesJ M Classe, I Jaffre, J S Frenel, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 25, 2010
Morbidity of diaphragmatic surgery for advanced ovarian cancer: retrospective study of 148 casesE Chéreau, R Rouzier, S Gouy, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 15, 2010
Hyperthermic intra-peritoneal chemotherapy using oxaliplatin as consolidation therapy for advanced epithelial ovarian carcinoma. Results of a phase II prospective multicentre trial. CHIPOVAC studyC Pomel, G Ferron, G Lorimier, et al.
Journal De Chirurgie|December 11, 2007
[Expert agreement on the minimal descriptive surgical report for peritoneal cancer]J M Bereder, J M Classe, M Ducreux, et al.
Pageof 8

Showing results (41-50 of 78) with videos related to

Sort By:
Pageof 8
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|April 22, 2014
[Radiotherapy as conservative therapy for sarcomas within the irradiated field]A Modesto, T Filleron, C Chevreau, et al.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|April 3, 2007
[Sentinel node detection applied to breast cancer: 2007 update]J-M Classe, G Houvenaeghel, C Sagan, et al.
Annals of Surgical Oncology|April 5, 2020
Should We Abandon Systematic Pelvic and Paraaortic Lymphadenectomy in Low-Grade Serous Ovarian Cancer?V Simon, C Ngo, E Pujade-Lauraine, et al.
Gynecologic Oncology|June 2, 2016
Results of a multicenter phase I dose-finding trial of hyperthermic intraperitoneal cisplatin after neoadjuvant chemotherapy and complete cytoreductive surgery and followed by maintenance bevacizumab in initially unresectable ovarian cancerS Gouy, G Ferron, O Glehen, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 4, 2009
Factors predicting the sentinel node metastases in T1 breast cancer tumor: an analysis of 1416 casesJ Capdet, P Martel, H Charitansky, et al.
Annals of Surgical Oncology|March 24, 2016
Surgical Complexity Impact on Survival After Complete Cytoreductive Surgery for Advanced Ovarian CancerA Martinez, C Ngo, E Leblanc, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 28, 2011
Prognostic factors for patients treated for a recurrent FIGO stage III ovarian cancer: a retrospective study of 108 casesJ M Classe, I Jaffre, J S Frenel, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 25, 2010
Morbidity of diaphragmatic surgery for advanced ovarian cancer: retrospective study of 148 casesE Chéreau, R Rouzier, S Gouy, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 15, 2010
Hyperthermic intra-peritoneal chemotherapy using oxaliplatin as consolidation therapy for advanced epithelial ovarian carcinoma. Results of a phase II prospective multicentre trial. CHIPOVAC studyC Pomel, G Ferron, G Lorimier, et al.
Journal De Chirurgie|December 11, 2007
[Expert agreement on the minimal descriptive surgical report for peritoneal cancer]J M Bereder, J M Classe, M Ducreux, et al.
Pageof 8